NIDDK Central Repository News
To subscribe to the NIDDK Central Repository news feed via email, register an account using the link in the header above and login for the first time to activate your account. NIH employees may login with their NIH credentials, no registration is needed. Upon login, users may update subscription preferences via their account profile.
Specimens and Updated Data Available For CIT-07 (Study Page)
Specimens and updated data are available to be requested for the Islet Transplantation in Type 1 Diabetes (CIT-07) study. See the Data Dictionary included on the study page for a complete list of datasets that are available for request.
The Islet Transplantation in Type 1 Diabetes (CIT-07) study is a prospective, multicenter, single-arm clinical trial that was conducted by the CITC to investigate the safety and efficacy of islet transplantation when combined with an immunosuppressive medication regimen for treating type 1 diabetes in individuals with hypoglycemia unawareness. Individuals with type 1 diabetes with type 1 diabetes, dependence on insulin for at least 5 years at study entry, and at least one episode of severe hypoglycemia in the past 12 months were eligible for enrollment.
Data Update for TrialNet 01 (Study Page)
Data have been updated for the TrialNet Pathway To Prevention (formerly Natural History Study) (TN01 NH). The research labs dataset has been updated and split into two datasets.
The primary aim of the study is to identify subjects for TrialNet prevention and investigation trials, but can also be used for assessing the predictive value of existing and novel risk markers of T1D, and for examining the demographic, immunologic, and metabolic characteristics of individuals at risk for developing T1D.
Data Update for TEDDY (Study Page)
Data have been updated for The Environmental Determinants of Diabetes in the Young (TEDDY). This update includes form data as well as five additional analysis datasets (M24. M54, M56, M57, and M77).
The TEDDY study is a multicenter prospective cohort study that was established in response to these gaps in understanding of T1D. The primary objectives of the study include identifying environmental factors—such as infectious agents, dietary factors, and psychosocial factors—that trigger or protect against the development of islet autoimmunity and T1D and examining genetic-environmental interactions to investigate interactive effects that contribute to T1D.
New Biorepository Location at Precision
The biorepository has moved to a new location at Precision for Medicine in Frederick, MD. All incoming shipments should be sent to the following address:
Precision for Medicine
8425 Precision Way, Suite M
Frederick, MD 21701
ATTN: Eduard Chani
Precision can be contacted via the following means:
Phone: 240-306-4100
Fax: 301 668 3416
Email: niddk.mailbox@precisionformedicine.com
All communication regarding shipments should be sent to the email address noted above, including the electronic manifests and notifications associated with incoming shipments. Study staff may contact the repository with any questions about the new location.
Data Update for TrialNet 01 (Study Page)
Data have been updated for the TrialNet Pathway To Prevention (formerly Natural History Study) (TN01 NH). The primary aim of the study is to identify subjects for TrialNet prevention and investigation trials, but can also be used for assessing the predictive value of existing and novel risk markers of T1D, and for examining the demographic, immunologic, and metabolic characteristics of individuals at risk for developing T1D. Data collected on patients recruited through 2016 are now available from the Repository.
Repository Website Moving to .gov
On or about January 27, the Repository website will get a facelift and move to a .gov URL. Please update your bookmarks once we move. All current registrations and site functionality will be available on the revised site. A sneak peek is provided. Click here to view.
